Page last updated: 2024-09-05

scoparianoside b and ursolic acid

scoparianoside b has been researched along with ursolic acid in 4 studies

Compound Research Comparison

Studies
(scoparianoside b)
Trials
(scoparianoside b)
Recent Studies (post-2010)
(scoparianoside b)
Studies
(ursolic acid)
Trials
(ursolic acid)
Recent Studies (post-2010) (ursolic acid)
5041,577101,083

Protein Interaction Comparison

ProteinTaxonomyscoparianoside b (IC50)ursolic acid (IC50)
Aldo-keto reductase family 1 member B10Homo sapiens (human)4
Glycogen phosphorylase, muscle formOryctolagus cuniculus (rabbit)8.9708
Basic phospholipase A2 1Naja melanoleuca (forest cobra)2.9
DNA polymerase betaRattus norvegicus (Norway rat)6.65
Neutrophil elastaseHomo sapiens (human)0.416
Receptor-type tyrosine-protein phosphatase FHomo sapiens (human)3.8
Tyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)4.1433
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)3.8872
Liver carboxylesterase 1Homo sapiens (human)0.1
Low molecular weight phosphotyrosine protein phosphataseHomo sapiens (human)7.2
Corticosteroid 11-beta-dehydrogenase isozyme 1Homo sapiens (human)1.9
Delta-type opioid receptorMus musculus (house mouse)3.6
Nuclear receptor ROR-gammaHomo sapiens (human)3.5333
Basic phospholipase A2 PLA-AProtobothrops flavoviridis2.5
Transcription factor p65Homo sapiens (human)0.031
Acidic phospholipase A2 EC-IEchis carinatus (saw-scaled viper)2.3
Ubiquitin carboxyl-terminal hydrolase 7Homo sapiens (human)7
Sentrin-specific protease 1Homo sapiens (human)1.2932
Protease Human immunodeficiency virus 18

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's4 (100.00)2.80

Authors

AuthorsStudies
Chen, C; Cheng, K; Dai, L; Hu, K; Li, H; Liu, L; Sun, H; Wen, X; Xu, Q; Yuan, H1
Fang, Z; Gou, W; Guo, J; Hou, W; Li, Y; Liu, Q; Ning, H; Sun, X; Wei, H1
Hua, D; Wu, X1
Gou, W; Guo, J; Hou, W; Li, Y; Liu, Q; Ning, H; Shang, H; Sun, X; Wei, H1

Reviews

2 review(s) available for scoparianoside b and ursolic acid

ArticleYear
Small-molecule inhibitors targeting small ubiquitin-like modifier pathway for the treatment of cancers and other diseases.
    European journal of medicinal chemistry, 2022, Apr-05, Volume: 233

    Topics: Humans; Neoplasms; Protein Processing, Post-Translational; Small Ubiquitin-Related Modifier Proteins; Sumoylation; Ubiquitin

2022
Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study.
    Journal of natural products, 2022, 05-27, Volume: 85, Issue:5

    Topics: Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cisplatin; Cysteine Endopeptidases; Drug Resistance, Neoplasm; Female; Humans; Molecular Docking Simulation; Ovarian Neoplasms; Structure-Activity Relationship; Triterpenes

2022

Other Studies

2 other study(ies) available for scoparianoside b and ursolic acid

ArticleYear
Synthesis and anti-inflammatory activity of saponin derivatives of δ-oleanolic acid.
    European journal of medicinal chemistry, 2021, Jan-01, Volume: 209

    Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Glycyrrhizic Acid; Humans; Interleukin-6; Liver; Macrophages; Male; Medicine, Chinese Traditional; Mice; Mice, Inbred BALB C; Oleanolic Acid; Pentacyclic Triterpenes; Phosphorylation; Sapogenins; Saponins; Tumor Necrosis Factor-alpha

2021
Discovery and radiosensitization research of ursolic acid derivatives as SENP1 inhibitors.
    European journal of medicinal chemistry, 2022, Jan-05, Volume: 227

    Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Molecular Structure; Structure-Activity Relationship; Triterpenes; Ursolic Acid

2022